Back to companies

ReShape Lifesciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

ReShape Lifesciences Inc (ReShape) formerly Obalon Therapeutics Inc, designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShape Vest system is a implanted device allows weight reduction while keeping the stomach in place. It provides ReShapeCare virtual health coaching programme, which encourages healthy lifestyle modifications for all patients undergoing medically assisted weight reduction, and ReShape Diabetes Bloc-Stim Neuromodulation, a preclinical technology being developed for the treatment of type 2 diabetes mellitus. ReShape is headquartered in San Clemente, California, the US.

Gain a 360-degree view of ReShape Lifesciences Inc and make more informed decisions for your business Gain a 360-degree view of ReShape Lifesciences Inc and make more informed decisions for your business Contact Us
Headquarters United States of America

Address 1001 Calle Amanecer, San Clemente, California, 92673


Telephone 1 949 4296680

No of Employees 40

Industry Medical Equipment

Ticker Symbol & Exchange RSLS (NASD)

Revenue (2022) $11.2M -17.4% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 26.8% (2022 vs 2021)

Market Cap* $4.3M

Net Profit Margin (2022) XYZ 11.5% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Products and Services

Products Brands
Lap-Band System ReShape Vest
ReShape Calibration Tubes
ReShapeCare
XYZ
XYZ
XYZ
Understand ReShape Lifesciences Inc portfolio and identify potential areas for collaboration Understand ReShape Lifesciences Inc portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In September, the company entered into an agreement with Biorad Medisys for Obalon Gastric balloon system.
2023 Contracts/Agreements In June, the company entered into an agreement with Hive Medical to Manage Prospective Lap-Band Leads From Initial Contact Through Surgical Consultation.
2021 Acquisitions/Mergers/Takeovers In June, the company merged with Obalon Therapeutics Inc.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters ReShape Lifesciences Inc Acutus Medical Inc Morphic Medical Inc Orexigen Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America
City San Clemente Carlsbad Boston La Jolla
State/Province California California Massachusetts California
No. of Employees 40 225 - -
Entity Type Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Dan W. Gladney Chairman Executive Board 2015 -
Paul F. Hickey President; Chief Executive Officer Senior Management 2022 -
Thomas Stankovich Chief Financial Officer Senior Management 2019 61
Tom Stankovich Chief Financial Officer Senior Management - -
Dov Gal Vice President - Regulatory Clinical Quality; Chief Compliance Officer Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into ReShape Lifesciences Inc key executives to enhance your sales strategy Gain insight into ReShape Lifesciences Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer